SUBSCRIBE
SUBSCRIBE
News   Business

Chromatin, Inc. Licenses Gene Stacking Technology to Syngenta Biotechnology, Inc. (SBI)

October 19, 2007 | 
1 min read
CHICAGO--(BUSINESS WIRE)--Chromatin Inc. announced today that it has entered into a research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin’s proprietary gene stacking technology.
Alliances
MORE ON THIS TOPIC
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate Clocks Largest IPO Since 2024 With $400M Raise
February 27, 2026
 · 
5 min read
 · 
Tristan Manalac
The Westin St. Francis in San Francisco, home of the J.P. Morgan Healthcare Conference.
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Viatris Will Cut Up to 10% of Global Workforce Over 3 Years
February 26, 2026
 · 
58 min read
 · 
BioSpace Editorial Staff
Control, Complex work, Businessman balancing on a ball
Deals
Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+
February 26, 2026
 · 
1 min read
 · 
Tristan Manalac